Hydrodissection of the Hepatoduodenal Ligament

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06190821

Acronym

Duodenal

Enrollment

Registered

2024-01-05

Start date

2022-07-20

Completion date

2025-02-20

Last updated

2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Lesions

Keywords

hepatic lesions, liver lesions, duodenum, hepato duodenal ligament

Brief summary

Percutaneous treatment of liver lesions adjacent to the duodenum exposes the duodenum to the risk of thermal injury, limiting removal and oncologic outcome. In this study the investigators investigate the feasibility of hepato duodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Major subject (≥18 years of age) * Subject who underwent percutaneous ablation of primary or secondary liver lesions at HUS that required per-procedure hepatoduodenal ligament hydrodissection in the interventional imaging department of the New Civil Hospital from January 2019 to July 2022. * Subject who has not expressed opposition to the reuse of their data for the purpose of this research.

Exclusion criteria

\- Opposition to the reuse of his/her data for the purpose of scientific research.

Design outcomes

Primary

Measure	Time frame	Description
Retrospective description of the hepatoduodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum	Files analysed retrospectively from January 01, 2019 to July 31, 2022 will be examined	This study is retrospective

Countries

France

Contacts

Primary ContactJulien GARNON, MD

julien.garnon@chru-strasbourg.fr33 3.69.55.03.04

Outcome results